2021
DOI: 10.1016/j.apmt.2021.101231
|View full text |Cite
|
Sign up to set email alerts
|

Orally administrated nucleotide-delivery particles from microfluidics for inflammatory bowel disease treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 38 publications
0
9
0
Order By: Relevance
“…Polysaccharides participate in many biological activities, such as cytoskeleton formation, energy metabolism, blood glucose regulation and immunity modulation, are biocompatible and biodegradable, and can be easily extracted, processed and modified. Polysaccharides extracted from plants (for example, alginate 105,106 , cellulose 107 , starch 108 , carrageenan 109 , pectin 110 , guar gum 109 , mannan 111 , glucomannan 112 and inulin 113 ), animals (for example, chitosan 101,114 , hyaluronate 5 and chondroitin sulfate 115 ) and microbes (for example, pullulan 116 and β-glucan 117 ) are being explored for oral drug delivery. Polysaccharide nanoparticle formulations can orally deliver small molecules, oligonucleotides, peptides and proteins 94 .…”
Section: Biological Materialsmentioning
confidence: 99%
See 1 more Smart Citation
“…Polysaccharides participate in many biological activities, such as cytoskeleton formation, energy metabolism, blood glucose regulation and immunity modulation, are biocompatible and biodegradable, and can be easily extracted, processed and modified. Polysaccharides extracted from plants (for example, alginate 105,106 , cellulose 107 , starch 108 , carrageenan 109 , pectin 110 , guar gum 109 , mannan 111 , glucomannan 112 and inulin 113 ), animals (for example, chitosan 101,114 , hyaluronate 5 and chondroitin sulfate 115 ) and microbes (for example, pullulan 116 and β-glucan 117 ) are being explored for oral drug delivery. Polysaccharide nanoparticle formulations can orally deliver small molecules, oligonucleotides, peptides and proteins 94 .…”
Section: Biological Materialsmentioning
confidence: 99%
“…Furthermore, proteins and peptides can form complexes or composites with other materials, such as metals and metal oxides 122 , polysaccharides 123 , and synthetic polymers 124 , through chemical reactions or gelation induced by changes in temperature, pH, or salt concentrations. Moreover, proteins and peptides can be modified to form or functionalize microparticles and nanoparticles; for example, methacrylated gelatin was polymerized by photocrosslinking to fabricate oral delivery particles 112 . Genetically engineered silk sericin nanospheres, which remained negatively charged in the intestine, were used for targeted delivery to positively charged proteins at inflammatory sites of the colon in a mouse model of ulcerative colitis 121 .…”
Section: Biological Materialsmentioning
confidence: 99%
“…Furthermore, investigations of chemical syntheses in various microreactors configurations may also represent an important base for designing chips for other purposes. Specifically, fluid dynamics analyses may be of good use for researchers aiming to fabricate microfluidic platforms for emerging biomedical applications, including non-invasive diagnosis devices [ 108 , 109 , 110 , 111 , 112 ], cell culture media (organs-on-a-chip) [ 113 , 114 , 115 , 116 , 117 ], and precise drug-delivery systems [ 118 , 119 , 120 , 121 ].…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%
“…employed microfluidics to fabricate colon-targeted microparticles for the oral delivery of ASOs against tumor necrosis factor alpha (TNF-α). The cationic Konjac glucomannan developed and gelatin methacryloyl microparticles loaded with ASO nanocomplex were coated by the acid resistant Eudragit FS30D shells which can prevent release of the encapsulated drugs in the stomach or small intestine and enhancing their accumulation in colon selectively [ 31 ]. The glucomannan provided specific mannose ligands for targeting the macrophages and oral delivery of the ASOs resulted in reduced TNF-α expression in the colonic macrophages, thus reducing the inflammatory responses.…”
Section: Prospects Of the Oral Delivery Of Nucleic Acidsmentioning
confidence: 99%